Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma

Although immunotherapy has been considered as a potent strategy for lung adenocarcinoma (LUAD), only a small part of patients was served as potentially clinical benefiters. Immunogenic cell death (ICD), a type...

Source: BMC Medical Genomics - August 8, 2023 Category: Genetics & Stem Cells Authors: Yingshu Cui, Yi Li, Shan Long, Yuanyuan Xu, Xinxin Liu, Zhijia Sun, Yuanyuan Sun, Jia Hu and Xiaosong Li Tags: Research Source Type: research